查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1534273

全球基因分析仪市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Genetic Analyzer Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 225 Pages | 商品交期: 最快1-2个工作天内

价格

全球基因分析仪市场需求预计将从 2023 年的 117.5 亿美元达到近 244.4 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 8.48%。

遗传分析仪是用于遗传分析的先进仪器，包括 DNA 定序、基因分型和基因表现谱。这些设备使研究人员和临床医生能够在分子层面上检查遗传物质，从而深入了解遗传变异、突变和遗传状况。这些分析仪使用微阵列分析、聚合酶炼式反应和下一代定序 (NGS) 等各种技术来提供准确且全面的遗传资料。这些资讯对于医学诊断、个人化医疗和基因研究的应用至关重要。透过识别与疾病和药物反应相关的遗传标记，这些分析仪支持标靶疗法的开发，并为基因组学和个人化医疗保健的进步做出贡献。

市场动态

由于遗传性疾病和慢性病的盛行率不断上升，以及对个人化医疗的需求不断增长，遗传分析仪市场正在迅速扩大。遗传分析仪为诊断和了解遗传状况提供了重要工具，从而实现更精确和个人化的治疗计划。基因分析技术的进步也推动了市场的成长。下一代定序 (NGS) 和基于 CRISPR 的技术等创新提高了遗传分析的准确性、速度和可扩展性。这些进步使得全面的全基因组研究和识别以前无法检测到的遗传变异成为可能，从而推进研究和临床应用。对基因组研究的日益重视以及将遗传资料整合到临床实践中进一步贡献了市场机会。政府和研究机构正在基因组学计划上投入资金，为采用基因分析仪创造了有利的环境。基因组资料库和生物库的扩展也支持新型诊断和治疗方法的开发。消费者对健康基因检测（包括血统和生活方式见解）兴趣的增加，为市场成长提供了额外的机会。随着公众对遗传资讯价值的认识不断提高，对可访问且可靠的遗传分析解决方案的需求不断增长。然而，高成本和复杂的监管要求可能会限制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球遗传分析仪市场的每个细分市场进行了包容性评估。基因分析仪产业的成长和趋势为这项研究提供了整体方法。

市场区隔

基因分析仪市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 试剂和试剂盒
  • 仪器仪表
  • 软体

通过测试

  • 预测性基因检测
  • 运营商测试
  • 产前和新生儿检测
  • 疾病诊断测试
  • 药物基因组测试
  • 其他的

按申请

  • 癌症
  • 遗传疾病
  • 心血管疾病
  • 罕见疾病
  • 传染病
  • 其他的

依技术

  • 新一代定序 (NGS)
  • 实时萤光定量PCR系统
  • 其他的

按最终用途

  • 医院
  • 研究与开发实验室
  • 诊断中心
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的基因分析仪市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。基因分析仪市场的主要参与者包括 Thermo Fisher Scientific、Abbott Laboratories、PerkinElmer Inc.、BioRad Laboratories、AutoGenomics Inc.、ELITech Group、IntegraGen、Quest Diagnostics Inc.、Hoffmann-La Roche AG、Celera Group、Qiagen、Danaher（造父变星）。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：遗传分析仪 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力测试分析
    • 市场吸引力分析：依应用分类
    • 按技术分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球基因分析仪市场分析：依产品

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 试剂和试剂盒
  • 仪器仪表
  • 软体

第 6 章：全球基因分析仪市场分析：通过测试

  • 测试概述
  • 历史和预测数据测试分析
  • 预测性基因检测
  • 运营商测试
  • 产前和新生儿检测
  • 疾病诊断测试
  • 药物基因组测试
  • 其他的

第 7 章：全球遗传分析仪市场分析：依应用分类

  • 概述：按应用
  • 历史与预测资料分析：按应用分类
  • 癌症
  • 遗传疾病
  • 心血管疾病
  • 罕见疾病
  • 传染病
  • 其他的

第 8 章：全球基因分析仪市场分析：依技术分类

  • 依技术概述
  • 按技术进行历史和预测数据分析
  • 新一代定序 (NGS)
  • 实时萤光定量PCR系统
  • 其他的

第 9 章：全球基因分析仪市场分析：依最终用途

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 医院
  • 研究与开发实验室
  • 诊断中心
  • 其他的

第 10 章：全球遗传分析仪市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 11 章：基因分析仪公司的竞争格局

  • 基因分析仪市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 12 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Thermo Fisher Scientific
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Abbott Laboratories
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PerkinElmer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioRad Laboratories
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AutoGenomics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ELITech Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • IntegraGen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Quest Diagnostics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Hoffmann-La Roche AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Celera Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Qiagen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Danaher (Cepheid)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112115348

The global demand for Genetic Analyzer Market is presumed to reach the market size of nearly USD 24.44 Billion by 2032 from USD 11.75 Billion in 2023 with a CAGR of 8.48% under the study period 2024-2032.

Genetic analyzers are advanced instruments for genetic analyses, including DNA sequencing, genotyping, and gene expression profiling. These devices enable researchers and clinicians to examine genetic material at a molecular level, providing insights into genetic variations, mutations, and hereditary conditions. These analyzers use various technologies, such as microarray analysis, polymerase chain reaction, and next-generation sequencing (NGS), to deliver accurate and comprehensive genetic data. This information is crucial for applications in medical diagnostics, personalized medicine, and genetic research. By identifying genetic markers linked to diseases and response to medications, these analyzers support the development of targeted therapies and contribute to advancements in genomics and personalized healthcare.

MARKET DYNAMICS

The genetic analyzer market is expanding rapidly due to the escalating prevalence of genetic disorders and chronic diseases, together with the growing demand for personalized medicine. Genetic analyzers provide essential tools for diagnosing and understanding genetic conditions, enabling more precise and individualized treatment plans. Technological advancements in genetic analysis technologies are also driving market growth. Innovations such as next-generation sequencing (NGS) and CRISPR-based technologies enhance genetic analyses' accuracy, speed, and scalability. These advancements enable comprehensive genome-wide studies and the identification of previously undetectable genetic variants, advancing research and clinical applications. The growing emphasis on genomic research and the integration of genetic data into clinical practice further contribute to market opportunities. Governments & research institutions are spending on genomics initiatives, creating a favorable environment for adopting genetic analyzers. The expansion of genomic databases and biobanks also supports the development of novel diagnostic & therapeutic approaches. The rise in consumer interest in genetic testing for health and wellness, including ancestry and lifestyle insights, presents additional opportunities for market growth. As public awareness of genetic information's value increases, there is a growing demand for accessible and reliable genetic analysis solutions. However, high costs and complex regulatory requirements may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Genetic Analyzer. The growth and trends of Genetic Analyzer industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Genetic Analyzer market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagents & Kits
  • Instruments
  • Software

By Test

  • Predictive Genetic Testing
  • Carrier Testing
  • Prenatal and Newborn Testing
  • Disease Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

By Application

  • Cancer
  • Genetic Diseases
  • Cardiovascular Diseases
  • Rare Diseases
  • Infectious Diseases
  • Others

By Technology

  • Next-generation Sequencing (NGS)
  • Real-Time PCR System
  • Others

By End-use

  • Hospitals
  • Research & Development Laboratories
  • Diagnostic Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Genetic Analyzer market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genetic Analyzer market include Thermo Fisher Scientific, Abbott Laboratories, PerkinElmer Inc., BioRad Laboratories, AutoGenomics Inc., ELITech Group, IntegraGen, Quest Diagnostics Inc., Hoffmann-La Roche AG, Celera Group, Qiagen, Danaher (Cepheid). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENETIC ANALYZER - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Test
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Reagents & Kits Historic and Forecast Sales By Regions
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY TEST

  • 6.1. Overview By Test
  • 6.2. Historical and Forecast Data Analysis By Test
  • 6.3. Predictive Genetic Testing Historic and Forecast Sales By Regions
  • 6.4. Carrier Testing Historic and Forecast Sales By Regions
  • 6.5. Prenatal and Newborn Testing Historic and Forecast Sales By Regions
  • 6.6. Disease Diagnostic Testing Historic and Forecast Sales By Regions
  • 6.7. Pharmacogenomic Testing Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Cancer Historic and Forecast Sales By Regions
  • 7.4. Genetic Diseases Historic and Forecast Sales By Regions
  • 7.5. Cardiovascular Diseases Historic and Forecast Sales By Regions
  • 7.6. Rare Diseases Historic and Forecast Sales By Regions
  • 7.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY TECHNOLOGY

  • 8.1. Overview By Technology
  • 8.2. Historical and Forecast Data Analysis By Technology
  • 8.3. Next-generation Sequencing (NGS) Historic and Forecast Sales By Regions
  • 8.4. Real-Time PCR System Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data Analysis By End-use
  • 9.3. Hospitals Historic and Forecast Sales By Regions
  • 9.4. Research & Development Laboratories Historic and Forecast Sales By Regions
  • 9.5. Diagnostic Centers Historic and Forecast Sales By Regions
  • 9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE GENETIC ANALYZER COMPANIES

  • 11.1. Genetic Analyzer Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF GENETIC ANALYZER INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Abbott Laboratories
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. PerkinElmer Inc.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. BioRad Laboratories
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. AutoGenomics Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. ELITech Group
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. IntegraGen
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Quest Diagnostics Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Hoffmann-La Roche AG
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Celera Group
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Qiagen
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Danaher (Cepheid)
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Test (USD MN)
  • Predictive Genetic Testing Market Sales By Geography (USD MN)
  • Carrier Testing Market Sales By Geography (USD MN)
  • Prenatal and Newborn Testing Market Sales By Geography (USD MN)
  • Disease Diagnostic Testing Market Sales By Geography (USD MN)
  • Pharmacogenomic Testing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Genetic Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Next-generation Sequencing (NGS) Market Sales By Geography (USD MN)
  • Real-Time PCR System Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research & Development Laboratories Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Genetic Analyzer Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genetic Analyzer Report
  • Market Research Process
  • Market Research Methodology
  • Global Genetic Analyzer Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Test
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Test (USD MN)
  • Predictive Genetic Testing Market Sales By Geography (USD MN)
  • Carrier Testing Market Sales By Geography (USD MN)
  • Prenatal and Newborn Testing Market Sales By Geography (USD MN)
  • Disease Diagnostic Testing Market Sales By Geography (USD MN)
  • Pharmacogenomic Testing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Genetic Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Next-generation Sequencing (NGS) Market Sales By Geography (USD MN)
  • Real-Time PCR System Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research & Development Laboratories Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.